Drug Type Monoclonal antibody |
Synonyms Apolizumab (USAN/INN), Monoclonal antibody SMART 1D10, Remitogen + [2] |
Target |
Action inhibitors |
Mechanism CD74 inhibitors(HLA-DR antigens-associated invariant chain inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |


| KEGG | Wiki | ATC | Drug Bank |
|---|---|---|---|
| D02967 | Apolizumab | - |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| B-cell lymphoma recurrent | Phase 2 | United States | 01 Oct 2000 | |
| Non-Hodgkin's lymphoma refractory | Phase 2 | United States | 01 Oct 2000 | |
| Solid tumor | Phase 1 | United States | - | - |
Phase 1 | 29 | sehizkefbc(lkilbcbtvz) = xgupviydqz harnuuzovu (qmsbhaebbd ) View more | - | 01 Jun 2005 |






